期刊
CURRENT TREATMENT OPTIONS IN NEUROLOGY
卷 15, 期 2, 页码 125-149出版社
CURRENT MEDICINE GROUP
DOI: 10.1007/s11940-012-0217-2
关键词
Hemorrhagic transformation; Parenchymal hemorrhage; Hemorrhagic infarction; Thrombolytics; Symptomatic hemorrhage; Asymptomatic hemorrhage; Management of HT; Treatment; Clinical predictors; Imaging; Ferritin; Blood pressure; Hyperglycemia
资金
- Remedy Pharmaceuticals
Hemorrhagic Transformation (HT) has been well recognized as a common cause of hemorrhage in ischemic stroke patients. Though this complication may occur independently, it has been particularly dreaded in the post rTPA patient and thus has been the focus for analysis of multiple thrombolytic trials. This review examines the effect of different clinical predictors for hemorrhagic transformation and summarizes pertinent clinical trials, with a focus on the rational for design of future studies. Although currently there are no official guidelines for the acute management of HT per se, based upon review of the literature regarding pertinent clinical predictors herein, an innovative approach for the acute management of the HT patient is proposed.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据